Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin by Fievet, Bruno T. et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
JCB
 
©
 
 The Rockefeller University Press, 0021-9525/2004/03/653/7 $8.00
The Journal of Cell Biology, Volume 164, Number 5, March 1, 2004 653–659
http://www.jcb.org/cgi/doi/10.1083/jcb.200307032 653
 
Report
 
Phosphoinositide binding and phosphorylation act 
sequentially in the activation mechanism of ezrin
 
Bruno T. Fievet,
 
1
 
 Alexis Gautreau,
 
1
 
 Christian Roy,
 
2
 
 Laurence Del Maestro,
 
1
 
 Paul Mangeat,
 
2
 
 Daniel Louvard,
 
1
 
 
and Monique Arpin
 
1
 
1
 
Laboratoire de Morphogenèse et Signalisation Cellulaires, UMR144 Centre National de la Recherche Scientiﬁque (CNRS), 
Institut Curie, 75248 Paris, Cedex 05, France
 
2
 
Université Montpellier, UMR 5539 CNRS, 34095 Montpellier, Cedex 05, France
 
zrin, a membrane–actin cytoskeleton linker, which
participates in epithelial cell morphogenesis, is held
inactive in the cytoplasm through an intramolecular
 
interaction. Phosphatidylinositol 4,5-bisphosphate (PIP
 
2
 
)
binding and the phosphorylation of threonine 567 (T567)
are involved in the activation process that unmasks both
membrane and actin binding sites. Here, we demonstrate
 
that ezrin binding to PIP
 
2,
 
 through its NH
 
2
 
-terminal domain,
is required for T567 phosphorylation and thus for the
E
 
conformational activation of ezrin in vivo. Furthermore, we
found that the T567D mutation mimicking T567 phosphor-
ylation bypasses the need for PIP
 
2
 
 binding for unmasking
both membrane and actin binding sites. However, PIP
 
2
 
binding and T567 phosphorylation are both necessary for
the correct apical localization of ezrin and for its role in
epithelial cell morphogenesis. These results establish that
PIP
 
2
 
 binding and T567 phosphorylation act sequentially to
allow ezrin to exert its cellular functions.
 
Introduction
 
Ezrin is a member of the ezrin/radixin/moesin (ERM) family
that acts as a linker between the plasma membrane and
the actin cytoskeleton. ERM proteins are involved in cell
adhesion, motility, morphogenesis, and also participate in
signal transduction pathways (Bretscher et al., 2002; Gau-
treau et al., 2002).
ERM proteins are recruited to the plasma membrane via
 
their NH
 
2
 
-terminal domain (
 
 
 
300 residues), which contains
both protein and phosphatidylinositol 4,5-bisphosphate
(PIP
 
2
 
) binding sites (Algrain et al., 1993; Niggli et al.,
1995). They bind to F-actin through the last 34 aa of their
COOH-terminal domain (Turunen et al., 1994). In the
cytoplasm, ERM proteins are maintained in an inactive con-
formation through an intramolecular interaction between
their NH
 
2
 
-terminal ERM association domain (N-ERMAD)
and the last 100 residues of the COOH-terminal ERM asso-
ciation domain (C-ERMAD). This interaction masks
membrane and F-actin binding sites (Gary and Bretscher,
1995; Magendantz et al., 1995).
The activation of ERM proteins, resulting in the unmasking
of their functional binding sites, occurs through conformational
 
changes triggered by events including the binding to PIP
 
2
 
 and
the phosphorylation of a conserved threonine in the actin
binding site of the C-ERMAD (T567 in ezrin). ERM proteins
phosphorylated at this conserved threonine are localized in
membrane extensions rich in actin (Nakamura et al., 1996;
Hayashi et al., 1999). Expression of ERM mutants mimicking
phosphorylated forms (threonine mutated to aspartic acid,
T567D mutation in ezrin) induces the formation of actin-rich
membrane projections such as lamellipodia or microvilli
(Oshiro et al., 1998; Yonemura et al., 1999; Gautreau et al.,
 
2000). In vitro
 
,
 
 the C-ERMAD phosphorylation strongly
weakens its interaction with the N-ERMAD (Matsui et al.,
1998; Simons et al., 1998). By looking at the crystal structure
of a complex between the N- and C-ERMADs of moesin, the
threonine residue is seen located at the interface of these
two domains (Pearson et al., 2000). Its phosphorylation is
predicted to destabilize the N-ERMAD–C-ERMAD inter-
action through both steric and electrostatic effects. These
observations imply that phosphorylation of this conserved
threonine contributes to the conformational activation of ERM
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proteins. However, although this phosphorylation is required,
it is not sufficient in vitro for the association of ERM proteins
with F-actin indicating that this phosphorylation event is only
one step of the activation process (Nakamura et al., 1999).
The binding to PIP
 
2
 
 has also been proposed to play an es-
sential role in the conformational activation of ERM proteins
(Nakamura et al., 1999; Yonemura et al., 2002). A PIP
 
2
 
 bind-
ing mutant of ezrin is not recruited to the plasma membrane,
suggesting that PIP
 
2
 
 binding is essential for the membrane lo-
calization of ERM proteins (Barret et al., 2000). Moreover, in
vitro
 
,
 
 PIP
 
2
 
 regulates the binding of ERM proteins to the cyto-
plasmic tail of several transmembrane proteins (Hirao et al.,
1996; Heiska et al., 1998) and together with the C-ERMAD
threonine phosphorylation, the binding to F-actin (Naka-
mura et al., 1999). The crystal structure of the N-ERMAD of
radixin complexed with the polar headgroup of PIP
 
2
 
 shows a
slight change of conformation in contrast to N-ERMAD
alone (Hamada et al., 2000). These observations indicate that
 
the binding to PIP
 
2
 
 is an additional step required in the con-
formational activation of ERM proteins.
To analyze the synergy between these two events in the
conformational activation of ezrin in vivo, we made use of
the mutations abolishing PIP
 
2
 
 binding alone or in combina-
tion with the T567D mutation. We demonstrate that PIP
 
2
 
binding is the primary requirement in the conformational
activation of ezrin followed by the threonine phosphoryla-
tion. Moreover, we show that this sequence of events is nec-
essary for the apical targeting of ezrin and for the morpho-
genesis of epithelial cells.
 
Results and discussion
 
PIP
 
2
 
 
 
 ezrin is maintained in an inactive conformation 
in the cytoplasm
 
To explore the role of PIP
 
2
 
 in the conformational activation
of ezrin, we used the LLC-PK1 epithelial cell line, which is
Figure 1. PIP2
  ezrin is restricted to 
the cytoplasm. (A) Localization of wt 
and PIP2
  ezrin by double fluorescence 
with anti–VSV G antibody (ezrin VSVG) 
and phalloidin (actin) with or without 
preextraction with a 0.5% Triton X-100 
buffer. Images of xz sections, and apical, 
median, basal focal xy sections are 
shown. wt ezrin is associated with actin 
of the apical microvilli. PIP2
  ezrin is 
present in the cytoplasm and is totally 
extracted with detergent. Bars, 10  m. 
(B) Association of wt, PIP2
 , T/D, and 
PIP2
  T/D ezrin with the cytoskeleton. 
Similar amount of total (Tot), soluble 
(Sol) or insoluble material (Ins) were 
analyzed by Western blotting with an 
anti–VSV G antibody. (C) Distribution of 
ezrin mutants in membrane and cytosol 
fractions. Total (Tot), cytosolic (Cyt), and 
membrane-associated material concen-
trated eightfold (Mb 8x) were immuno-
blotted with anti–VSV G antibody. The 
amount of ezrin was quantified by 
densitometric analysis of serially diluted 
fractions obtained from three independent 
experiments. Average values are given   
SEM. (D) wt ezrin is released from the 
membrane and extracted with Triton
X-100 buffer ( ext) after ionomycin 
treatment (iono). 
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derived from the kidney proximal tubule and develops mi-
crovilli at the apical surface. We derived stable clones pro-
ducing an ezrin variant in which the binding to PIP
 
2
 
 is abol-
ished (PIP
 
2
 
 
 
 ezrin; Barret et al., 2000). This ezrin mutant
has two lysine doublets mutated to asparagine (K253/254N
and K262/263N). Wild-type (wt) ezrin was mainly localized
at the apical microvilli but also observed as a weak diffuse
staining corresponding to the cytoplasmic pool and as a faint
signal at cell–cell contacts. In contrast, the PIP
 
2
 
 
 
 ezrin was
completely cytoplasmic and absent from microvilli (Fig. 1
A). To assess the ability of PIP
 
2
 
 
 
 ezrin to associate with the
actin cytoskeleton we performed, before immunofluores-
cence, an extraction with a Triton X-100 buffer preserving
the cytoskeleton and cytoskeleton-associated proteins. No
staining could be detected in cells expressing PIP
 
2
 
 
 
 ezrin in
contrast to wt ezrin, which remained associated with the mi-
crovillus actin cytoskeleton (Fig. 1 A). Quantification after
Western blot analysis of soluble and insoluble fractions con-
firmed that PIP
 
2
 
 
 
 ezrin was threefold less insoluble than wt
ezrin (Fig. 1 B). This indicates that PIP
 
2
 
 
 
 ezrin cannot bind
to the actin cytoskeleton. Therefore, we quantified the
amount of ezrin in the membrane and cytosolic pools after
cell fractionation. We found a threefold reduction in the
amount of PIP
 
2
 
 
 
 ezrin in the membrane fraction in compar-
ison with wt ezrin showing that PIP
 
2
 
 
 
 ezrin can no longer be
recruited at the membrane (Fig. 1 C). To confirm the role of
PIP
 
2
 
 in the recruitment of ezrin to the membrane, we
treated cells with ionomycin in presence of Ca
 
2
 
 
 
. This phar-
macological treatment leads to the hydrolysis of PIP
 
2
 
 (Vár-
nai and Balla, 1998). After 30 min, wt ezrin was released
from the membrane and resided in the cytoplasm where
upon it became fully extractable with Triton X-100 buffer
(Fig. 1 D). Thus, in these treated cells, wt ezrin behaved
similarly to PIP
 
2
 
 
 
 ezrin. Because the cytoplasmic localiza-
tion of PIP
 
2
 
 
 
 ezrin is not due to a folding defect, confirmed
 
by both tryptophan fluorescence spectrum analysis and chy-
motrypsin digestion (unpublished data), we conclude that
the cytoplasmic localization of PIP
 
2
 
 
 
 ezrin is due to its in-
ability to bind PIP
 
2
 
.
The accumulation of PIP
 
2
 
 
 
 ezrin in the cytoplasm sug-
gests either that PIP
 
2
 
 is the major membrane binding part-
ner of ezrin or alternatively that PIP
 
2
 
 is required for its
conformational activation unmasking other NH
 
2
 
-terminal
membrane binding sites. To discriminate between these two
possibilities we derived stable LLC-PK1 clones expressing
the NH
 
2
 
-terminal domain either in its wt form (Nter ezrin)
or carrying the PIP
 
2
 
 
 
 mutation (NterPIP
 
2
 
 
 
 ezrin). We
showed that both Nter ezrin and NterPIP
 
2
 
 
 
 ezrin were local-
ized at the membrane in an unpolarized manner and were
not found in the cytoplasm (Fig. 2 A). Consistent with these
fluorescence data, analysis of membrane and cytosolic pools
indicated that both Nter ezrin and NterPIP
 
2
 
 
 
 ezrin were
almost exclusively in the membrane fraction (Fig. 2 B).
This result highlights the importance of the N-ERMAD–
C-ERMAD interaction in the regulation of the recruitment
of ezrin at the membrane because, in comparison, only 10%
of full-length ezrin is present at the membrane (Fig. 1 C). Most
importantly, it demonstrates that PIP
 
2
 
 is not the major
membrane partner that dictates the membrane association of
ezrin but is the primary requirement in the conformational
activation of the full-length molecule unmasking other
membrane binding sites. Altogether, these results indicate
that PIP
 
2
 
 
 
 ezrin is cytoplasmic because it is maintained in an
inactive conformation.
Figure 2. Membrane localization of Nter and NterPIP2
  ezrin. 
(A) Fluorescence was performed as in Fig. 1. Nter and NterPIP2
  
ezrin are localized at the membrane but in a nonpolarized manner. 
Bar, 10  m. (B) Distribution of ezrin mutants in membrane and 
cytosol fractions. Total (Tot), cytosol (Cyt), and membrane-associated 
material (Mb) were immunoblotted with an anti–VSV G antibody.
Figure 3. Ezrin phosphorylation at T567 requires the interaction 
of the N-ERMAD with PIP2. (A) Immunoprecipitated wt and PIP2
  
ezrin were analyzed by Western blot with an anti–VSV G antibody 
(VSVG) or with an antibody recognizing ezrin phosphorylated at 
T567 (T567P).  PPase indicates than immunoprecipitated proteins 
were treated with  -phosphatase. In contrast to wt ezrin, PIP2
  ezrin 
is not phosphorylated at T567. (B) After transient transfection, wtPH 
and PIP2
  PH ezrin were localized by immunofluorescence with 
an anti–VSV G antibody. Both proteins are localized at the plasma 
membrane and in microvilli. Bar, 10  m. (C) Distribution of wtPH 
and PIP2
  PH ezrin in membrane and cytosol fractions was obtained 
as in Fig. 2. (D) Immunoprecipitated wtPH ezrin is phosphorylated 
at T567, whereas PIP2
  PH ezrin is not phosphorylated. 
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Ezrin phosphorylation at T567 requires the interaction 
of the N-ERMAD with PIP
 
2
 
Because the T567 phosphorylation of ezrin has been shown
to play an important role in its conformational activation, we
examined the level of T567 phosphorylation of PIP
 
2
 
 
 
 ezrin
using a T567 phosphospecific antibody. Western blots were
performed after gel electrophoresis of immunoprecipitated
proteins. Although a signal was detected with wt ezrin,
which corresponded to the phosphorylated protein because it
was abolished after phosphatase treatment, no signal was ob-
served with PIP
 
2
 
 
 
 ezrin (Fig. 3 A). This result indicates that
the binding of ezrin to PIP
 
2
 
 is required for and precedes
T567 phosphorylation in the mechanism of ezrin activation.
The interaction of ezrin with PIP
 
2
 
 could target the protein at
the membrane at the vicinity of the kinase. To test this hy-
pothesis, we fused wt and PIP
 
2
 
 
 
 ezrin to the pleckstrin ho-
mology (PH) domain of the phospholipase C-
 
 
 
1 (wtPH and
PIP
 
2
 
  
 
PH ezrin), which interacts with PIP
 
2
 
 at the plasma
membrane, and we analyzed the subcellular distribution and
the phosphorylation of these chimeras after transient trans-
fection of LLC-PK1 cells. Both wtPH and PIP
 
2
 
 
 
 PH ezrin
 
were localized at the plasma membrane and in the microvilli
(Fig. 3 B). After cell fractionation, both chimeras were found
almost exclusively in the membrane fraction (Fig. 3 C). Al-
though these two chimeras had the same localization in the
cells, only wtPH ezrin was phosphorylated at T567 (Fig. 3
D). Altogether, these results show that the targeting of ezrin
to the membrane is not sufficient for its phosphorylation at
T567. Rather, our results indicate that the interaction of the
ezrin N-ERMAD with PIP
 
2
 
 is necessary for the subsequent
phosphorylation of T567. This suggests that the interaction
of the N-ERMAD with PIP
 
2
 
 induces a conformational rear-
rangement that allows the phosphorylation at T567. Such a
conformational change has been observed upon analysis of
the crystal structure of the N-ERMAD complexed to the po-
lar headgroup of PIP
 
2
 
 (Hamada et al., 2000).
 
The T567D mutation restores the membrane–
cytoskeleton linker capacity of 
 
PIP
 
2
 
 
 
 ezrin
 
Because the binding of ezrin to PIP
 
2
 
 is required for its subse-
quent phosphorylation, we determined whether the T567D
mutation in the PIP
 
2
 
 
 
 ezrin mutant (PIP
 
2
 
 
 
 T/D ezrin)
Figure 4. Unpolarized localization of 
T/D and PIP2
  T/D ezrin at the plasma 
membrane. Fluorescence was performed 
as in Fig. 1. T/D ezrin was mainly located 
on the dorsal surface of the cells and in 
cell–cell contacts. PIP2
  T/D ezrin was 
uniformly distributed at the plasma 
membrane. T/D and PIP2
  T/D ezrin 
remained associated with the cortical 
actin cytoskeleton after extraction with 
the Triton X-100 buffer. Bars, 10  m. 
(B) Membrane localization of T567D 
and PIP2
  T/D ezrin and cytoskeleton 
association are preserved after ionomycin 
treatment followed by extraction with 
the Triton X-100 buffer before fixation.PIP2 and phosphorylation in ezrin activation | Fievet et al. 657
would be sufficient to restore the apical membrane localiza-
tion and the binding to the actin cytoskeleton. Whereas
PIP2
  ezrin was found restricted to the cytoplasm (Fig. 1 A),
PIP2
  T/D ezrin was also recruited to the plasma mem-
brane, similar to ezrin carrying the T567D mutation alone
(T/D ezrin; Fig. 4 A). This suggests that the T567D muta-
tion allows the unmasking of the PIP2-independent mem-
brane binding sites (Fig. 1 C). In addition, both T/D ezrin
and PIP2
  T/D ezrin remained associated with the cortical
actin cytoskeleton after extraction of cells with the Triton
X-100 buffer indicating that T567D mutation is sufficient
to unmask the actin binding site independently of PIP2 bind-
ing (Fig. 1 B and Fig. 4 A). Moreover, ionomycin treatment
had no effect on either the membrane localization or the as-
sociation with the actin cytoskeleton of both T/D and PIP2
 
T/D ezrin (Fig. 4 B). Altogether, our results show that the
T567D mutation restores the capacity of PIP2
  ezrin to act
as a membrane–actin cytoskeleton linker and demonstrates
that binding of ezrin to PIP2 is dispensable for the unmask-
ing of functional binding sites in vivo, in contrast to what
was described in vitro (Nakamura et al., 1999).
However, neither PIP2
  T/D ezrin, nor T/D ezrin had a
restricted apical localization (Fig. 4 A). The factors control-
ling the apical localization of ezrin are still unknown. But
our results indicate that the release of the N-ERMAD–
C-ERMAD interaction leading to the unmasking of PIP2
independent membrane binding sites is not sufficient, in it-
self, for the apical localization of ezrin. This indicates that
regulated unmasking of the membrane binding sites in the
NH2-terminal domain is required for this apical localization
consistent with our observations using the Nter mutants
(Fig. 2 A). The sequence of events consisting of binding to
PIP2 followed by phosphorylation at T567 is critical for the
restricted apical localization of wt ezrin.
Unlike T/D ezrin, PIP2
  T/D ezrin does not alter 
epithelial cell morphology
We have shown previously that production of T/D ezrin in
epithelial cells induced the formation of lamellipodia, mem-
brane ruffles, tufts of microvilli, and impaired cell–cell con-
tacts indicating a critical role for ezrin in epithelial cell mor-
phogenesis (Gautreau et al., 2000; Pujuguet et al., 2003).
To test whether ezrin binding to PIP2 is necessary for its role
in epithelial cell morphogenesis we analyzed the surface of
cells expressing PIP2
  and PIP2
  T/D ezrin by scanning
electron microscopy (Fig. 5). In contrast to cells producing
T/D ezrin, we observed that cells producing PIP2
  T/D
ezrin formed a regular monolayer with surface microvilli re-
sembling those of cells overexpressing wt ezrin (Fig. 5). This
suggests that despite the ability of PIP2
  T/D ezrin to act as
a linker between the membrane and the actin cytoskeleton,
its expression does not affect epithelial cell morphology as
seen with T/D ezrin. This suggests that the conformational
activation unmasking functional binding sites alone is not
sufficient to allow ezrin to exert its signaling functions.
Therefore, correct regulation of ezrin activation is depen-
dent on the binding of ezrin to PIP2.
We observed that although cells expressing PIP2
  ezrin
formed a well-organized monolayer, they displayed, on their
apical surface, fewer and shorter microvilli compared with
the abundant and regular microvilli seen on cells expressing
wt ezrin. Thus, production of PIP2
  ezrin had a strong dom-
inant negative effect on microvillus formation. We did not
detect any effect of PIP2
  ezrin on the amount and localiza-
tion of the phosphorylated endogenous ERM proteins (un-
published data). This indicates that the absence of microvilli
in cells producing PIP2
  ezrin is not due to a dominant neg-
ative effect on the activation of endogenous ERM proteins,
but rather is due to an effect on a downstream effector of
ezrin involved in microvillus formation.
Recently, genetic analysis of Drosophila moesin, the only
ERM protein in this organism, has stressed the role of this
protein in the control of epithelial cell integrity and polarity
(Polesello et al., 2002; Speck et al., 2003). Our experiments
have demonstrated that to exert its cellular functions at the
apical pole of epithelial cells, ezrin undergoes a conforma-
tional activation, which requires primarily PIP2 binding and
the subsequent phosphorylation at T567. Future works us-
ing these well-characterized mutants of ezrin should further
the understanding of how the regulated conformational acti-
vation of ezrin controls its signaling functions in the devel-
opment and maintenance of epithelial cell polarity.
Figure 5. Binding of ezrin to PIP2 is required for its function in 
epithelial cell morphogenesis. Scanning electron microscopy of 
confluent cells grown on filters for 4 d producing wt, T/D, PIP2
 , 
and PIP2
  T/D ezrin. Clones producing PIP2
  ezrin formed a well-
organized monolayer displaying shorter and more disperse microvilli 
on their cell surface as compared with cells producing wt ezrin. 
Cells producing PIP2
  T/D ezrin did not show the aberrant morphology 
observed with cells producing T/D ezrin. Bars, 2  m.658 The Journal of Cell Biology | Volume 164, Number 5, 2004
Materials and methods
Cell culture
LLC-PK1 cells (CCL 101; American Type Culture Collection) were grown in
DME (GIBCO BRL) and supplemented with 10% FCS, at 37 C in 10% CO2.
Antibodies
The mouse monoclonal anti–vesicular stomatitis virus glycoprotein (VSV
G) antibody (clone P5D4) was described previously (Kreis, 1986). T567
phospho-ezrin pAb was purchased from Cell Signaling Technology.
DNA constructs and stable transfection
The pCB6 vectors containing cDNA coding for VSV G–tagged ezrin carry-
ing the K253N, K254N, K262N, and K263N mutations (PIP2
  ezrin) or the
T567D mutation (T/D ezrin) were described previously (Barret et al., 2000;
Gautreau et al., 2000). The pCB6 vector containing cDNA coding for VSV
G–tagged Nter ezrin (1-309) was described previously (Algrain et al.,
1993). The pCB6 vectors containing cDNA coding for wtPH and PIP2
  PH
ezrin were obtained by an in-frame insertion of a fragment coding for the
PH domain of rat phospholipase C- 1 (10-139) at the 3  end of the VSV
G–ezrin cDNA. All constructs were obtained by standard techniques and
verified by sequencing. Stable LLC-PK1 clones were obtained as described
previously (Gautreau et al., 2000). All experiments were performed with
three independent clones for each construct and gave similar results.
Immunofluorescence
10
5 cells were seeded on 1-cm
2 polyester filters (Transwell; Costar Corp.)
and grown for 4 d. Cells were fixed with 3% PFA and permeabilized with
0.5% Triton X-100. Cells were subsequently incubated with anti–VSV G
antibody and then with Alexa 488–conjugated goat anti–mouse secondary
antibody (Jackson ImmunoResearch Laboratories) and with TRITC-labeled
phalloidin (Sigma Chemical Co.). The samples were analyzed with an SP2
confocal laser scanning microscope (Leica). When indicated, living cells
were incubated for 30 min with 10 mM CaCl2 and 30  M ionomycin
(Sigma Chemical Co.) in PBS. Extraction was performed before fixation by
treating the cells for 1 min with a Triton X-100 buffer (50 mM MES, 3 mM
EGTA, 5 mM MgCl2, 0.5% Triton X-100, pH 6.4) at 20 C.
Scanning electron microscopy
5   10
5 cells were seeded on 4.7 cm
2 polycarbonate filters and grown for
4 d. Samples were fixed with 2.5% glutaraldehyde, dehydrated in a graded
series of ethanol incubation, dried by the critical point method using liquid
CO2, coated with gold palladium, and observed with a microscope (model
JSM 840A; JEOL).
Immunoprecipitation
Immunoprecipitations were performed as described previously (Gautreau
et al., 2000). When indicated, immunoprecipitated proteins were treated
with  -phosphatase (New England Biolabs, Inc.) according to the manufac-
turer’s instructions.
Analysis of detergent-soluble and -insoluble fractions
Cellular fractions were obtained from 6-well plates confluent cultures. To-
tal cellular fractions were collected with Laemmli buffer at 100 C. Soluble
fractions were prepared by a 1-min extraction with Triton X-100 buffer at
20 C and supplemented with 3  Laemmli buffer. The insoluble fractions
were extracted with Laemmli buffer at 100 C. Samples were analyzed by
SDS-PAGE and immunoblotting. Densitometric analysis were performed
with the Scion image program (NIH image).
Cytosol/membrane fractionation
Confluent cultures from 10-cm dishes were mechanically disrupted using a
cell cracker in 10 mM Hepes, 1 mM EDTA, 150 mM NaCl, pH 7.4, buffer
containing a cocktail of protease inhibitors. The homogenates were clari-
fied by centrifugation at 600 g. An aliquot of the supernatant was supple-
mented with 3  Laemmli buffer and corresponded to the total fraction.
The supernatant was subjected to a 30-min centrifugation at 100,000 g.
The resulting supernatant was supplemented with 3  Laemmli buffer (cy-
tosolic fraction) and the membrane pellets were solubilized in Laemmli
buffer (membrane fraction). Samples were analyzed by SDS-PAGE and im-
munoblotting.
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